Form N-23C3A Columbia Credit Income For: Feb 09 Feb 9, 2026 09:11AM   

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form N-23c-3

Notification of Repurchase Offer

Pursuant to Rule 23c-3 [17 CFR 270.23c-3]

 

1.

Investment Company Act File Number: 811- 24028

 

2.

Date of Notification: February 9, 2026

 

3.

Exact name of investment company as specified in registration statement:

COLUMBIA CREDIT INCOME OPPORTUNITIES FUND

 

4.

Address of principal executive office:... (continue reading...)


Form 6-K PEARSON PLC For: Feb 09 Feb 9, 2026 09:11AM   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 6-K     REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934     For the month of February 2026     PEARSON plc (Exact name of registrant as specified in its charter)   N/A   (Translation of registrant's name into English)   80 Strand London, England WC2R 0RL 44-20-7010-2000 (Address of... (continue reading...)
Form 13F-HR Frazier Financial Adviso For: Dec 31 Feb 9, 2026 09:11AM .FormData { color: blue; background-color: white; font-size: small; font-family: Times, serif; } .FormDataC { color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center; } .FormDataR { color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align:... (continue reading...)
Form 25-NSE V F CORP Filed by: NEW YORK STOCK EXCHANGE LLC Feb 9, 2026 09:10AM

ATTACHMENTS / EXHIBITS

primary_doc.xml

ruleprovisionnotice.htm


Form 13F-HR Powell Investment Adviso For: Dec 31 Feb 9, 2026 09:10AM .FormData { color: blue; background-color: white; font-size: small; font-family: Times, serif; } .FormDataC { color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center; } .FormDataR { color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align:... (continue reading...)

More SEC Filings

View Older Stories

Feb 9, 2026 09:07AM Form 424B2 ROYAL BANK OF CANADA
Feb 9, 2026 09:07AM Form 25-NSE Lemonade, Inc. Filed by: NYSE AMERICAN LLC
Feb 9, 2026 09:07AM Form 424B2 BANK OF MONTREAL /CAN/
Feb 9, 2026 09:07AM Form D/A 275 Funding, LLC
Feb 9, 2026 09:06AM Form ABS-15G Zolve Financials LLC For: Dec 31
Feb 9, 2026 09:05AM Form 424B2 BANK OF MONTREAL /CAN/
Feb 9, 2026 09:04AM Form FWP National Bank Holdings Filed by: National Bank Holdings Corp
Feb 9, 2026 09:04AM Form 6-K ParaZero Technologies For: Feb 09
Feb 9, 2026 09:04AM Form 8-K SM Energy Co For: Feb 04
Feb 9, 2026 09:03AM Form F-1/A Horizon Thread (PTY)
Feb 9, 2026 09:03AM Form 497J FT 12718
Feb 9, 2026 09:02AM Form 497J FT 12782
Feb 9, 2026 09:01AM Form 497J FT 12742
Feb 9, 2026 09:01AM Form SCHEDULE 13D/A Commercial Vehicle Group Filed by: Lakeview Opportunity Fund LLC
Feb 9, 2026 09:00AM Form 8-K FB Bancorp, Inc. /MD/ For: Feb 09
Feb 9, 2026 09:00AM Form 8-K Valaris Ltd For: Feb 09
Feb 9, 2026 09:00AM Form SCHEDULE 13G/A Ryerson Holding Corp Filed by: JB CAPITAL PARTNERS LP
Feb 9, 2026 09:00AM Form 6-K Diginex Ltd For: Jan 30
Feb 9, 2026 09:00AM Form 6-K Energys Group Ltd For: Feb 09
Feb 9, 2026 09:00AM Form 6-K ASCENTAGE PHARMA GROUP For: Feb 09
Feb 9, 2026 09:00AM Form 8-K TriSalus Life Sciences, For: Feb 03
Feb 9, 2026 09:00AM Form 497J FT 12741
Feb 9, 2026 08:59AM Form 13F-HR Catalyst Funds Managemen For: Dec 31
Feb 9, 2026 08:59AM Form 8-K SYNCHRONOSS TECHNOLOGIES For: Feb 09
Feb 9, 2026 08:59AM Form 497J FT 12739
Feb 9, 2026 08:59AM Form 424B5 National Bank Holdings
Feb 9, 2026 08:58AM Form 13F-HR Fox Financial, Inc For: Dec 31
Feb 9, 2026 08:57AM Form SCHEDULE 13G/A Liquidia Corp Filed by: Farallon Capital Partners, L.P.
Feb 9, 2026 08:56AM Form 13F-HR Darden Wealth Group Inc For: Dec 31
Feb 9, 2026 08:55AM Form 8-K Limitless X Holdings For: Jan 26
Feb 9, 2026 08:55AM Form SCHEDULE 13G/A AGIOS PHARMACEUTICALS, Filed by: Farallon Capital Partners, L.P.
Feb 9, 2026 08:54AM Form 13F-HR OLD REPUBLIC INTERNATION For: Dec 31
Feb 9, 2026 08:53AM Form SCHEDULE 13G/A Revolution Medicines, Filed by: Farallon Capital Partners, L.P.
Feb 9, 2026 08:53AM Form SCHEDULE 13G/A LIFETIME BRANDS, INC Filed by: JB CAPITAL PARTNERS LP
Feb 9, 2026 08:53AM Form 8-K Nukkleus Inc. For: Feb 09
Feb 9, 2026 08:52AM Form 8-K AVANT TECHNOLOGIES INC. For: Feb 03
Feb 9, 2026 08:51AM Form TA-2 NORTHEAST INVESTORS TRUS For: Dec 31
Feb 9, 2026 08:51AM Form SCHEDULE 13G/A Beta Bionics, Inc. Filed by: Farallon Capital Partners, L.P.
Feb 9, 2026 08:50AM Form 3 Entera Bio Ltd. For: Feb 04 Filed by: Germano Geno J
Feb 9, 2026 08:50AM Form 6-K VODAFONE GROUP PUBLIC For: Feb 09
Feb 9, 2026 08:49AM Form SCHEDULE 13G/A GRAIL, Inc. Filed by: Farallon Capital Partners, L.P.
Feb 9, 2026 08:47AM Form SCHEDULE 13G/A Fluent, Inc. Filed by: JB CAPITAL PARTNERS LP
Feb 9, 2026 08:47AM Form SCHEDULE 13G/A ASSEMBLY BIOSCIENCES, Filed by: Farallon Capital Partners, L.P.
Feb 9, 2026 08:46AM Form 8-K Entera Bio Ltd. For: Feb 04
Feb 9, 2026 08:46AM Form 8-K BITMINE IMMERSION TECHNO For: Feb 09
Feb 9, 2026 08:45AM Form 8-K Turn Therapeutics Inc. For: Feb 09
Feb 9, 2026 08:40AM Form 4 SOUTHERN CO For: Feb 05 Filed by: Poroch David P.
Feb 9, 2026 08:39AM Form 4 SOUTHERN CO For: Feb 05 Filed by: Cherry Pedro P.
Feb 9, 2026 08:39AM Form 4 SOUTHERN CO For: Feb 05 Filed by: Kim Matthew M.
Feb 9, 2026 08:37AM Form 6-K Cadeler A/S For: Feb 09
View Older Stories